The $41.1 billion merger of Schering-Plough and Merck & Co has been overwhelmingly approved by the shareholders of each company. Nearly four fifths of the total shareholding voted in the proceedings, with near unanimous backing.
A preliminary count showed that 99% of the votes cast supported the tie-up as the firms power towards a fourth-quarter...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?